Welcome to our dedicated page for Travelers Compan SEC filings (Ticker: TRV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hurricane season loss trends, asbestos reserve movements, and commercial premium pricing make Travelers Companies filings uniquely data-rich. Whether you’re comparing combined ratios or tracking how management prices catastrophe reinsurance, every 10-K and 10-Q reveals insights that drive this insurer’s results.
Stock Titan’s AI turns those dense disclosures into clarity. Need the Travelers Companies quarterly earnings report 10-Q filing in plain language? Our AI-powered summaries highlight net written premium growth, reserve development, and investment portfolio yields in seconds. Wondering about Travelers Companies insider trading Form 4 transactions? Receive real-time alerts the moment executives buy or sell shares, with context around claim seasonality and capital returns.
- Annual report 10-K simplified – pinpoint catastrophe exposure tables, statutory surplus data, and segment profitability without scrolling 300 pages.
- 8-K material events explained – understand dividend declarations, hurricane loss estimates, or senior note offerings minutes after EDGAR posts.
- Proxy statement executive compensation – see how combined ratio targets drive bonus pools and compare CEO pay to peers.
- Form 4 insider transactions real-time – follow underwriting leadership’s trades to gauge confidence in reserve adequacy.
Our coverage spans every filing type, from Travelers Companies earnings report filing analysis to shelf registrations. AI-driven search answers natural questions like “How to read Travelers Companies 10-K” or “Where can I find Travelers Companies executive stock transactions Form 4.” Stop wading through actuarial jargon; understand Travelers Companies SEC filings explained simply with concise takeaways, expert context, and live updates that surface what matters most to property-casualty investors.
Insider transaction summary: The Form 4 shows insider Rowland David Donnay, EVP & Co-Chief Investment Officer of The Travelers Companies, Inc. (TRV), reported transactions dated 08/18/2025. The filing records a distribution of 2,034 shares from a GRAT to another trust and a transfer that moved 3,131 shares from indirect trust holdings to direct ownership. After the reported disposition, Mr. Donnay beneficially owned 12,686 shares indirectly (held in trust) and directly held additional shares including 5,837.775 shares in a 401(k) plan and 14,862.385 shares
Alan D. Schnitzer, Chairman and CEO of The Travelers Companies, Inc. (TRV), filed a Form 4 reporting transactions dated 08/14/2025. The filing shows a transaction code G for the acquisition of 2,570 shares of Common Stock at a price of $0, and reports 11,091 shares beneficially owned indirectly by spouse following the transaction. The filing also lists a separate entry showing 260,329.401 shares marked as disposed (D) in Common Stock. The report includes an explanatory statement that the reporting person disclaims beneficial ownership of these securities. The Form is signed by Wendy C. Skjerven by power of attorney on 08/15/2025.
Andy F. Bessette, EVP and Chief Administrative Officer of The Travelers Companies (TRV), reported a same-day option exercise and sale. He exercised 7,742 stock options at $172.50 per share and sold 7,742 shares at $264.90 per share on 08/07/2025, leaving him with 20,691.577 shares directly and 1,696.08 shares held indirectly in a 401(k) plan.
The Form 144 filing discloses that an affiliate of The Travelers Companies, Inc. (NYSE: TRV) intends to sell 7,742 common shares on or about 08/07/2025 through Fidelity Brokerage Services. Based on the filing’s reference price, the planned sale is valued at $2.05 million, representing roughly 0.003% of the company’s 225.1 million shares outstanding. The shares stem from stock options granted on 02/08/2022 that will be settled for cash.
The filer, identified as Andy Bessette, previously sold 5,000 shares for $1.36 million on 05/16/2025, bringing total disclosed sales within three months to 12,742 shares worth ≈$3.41 million. The filer certifies no undisclosed material adverse information and that the sale complies with Rule 144.
No financial performance data or operational updates accompany this notice; the filing strictly signals a modest insider sale that is immaterial to share count but may interest investors tracking insider trading patterns.